Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWITCH-1
NCT02583685Phase 2Completed
- Sponsor
- Humanity & Health Research Centre
- Start
- May 2015
- Primary completion
- Oct 2024
- Modality
- Implantable Devices, Reversible Covalent Inhibitors, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 2 trial of Harvoni, asunaprevir, simeprevir in hepatitis C (HCV), sponsored by Humanity & Health Research Centre. Started May 2015; status: completed.
02
Drugs
Harvoniasunaprevirsimeprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02583685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02583685.